US Government to Start Imposing Inflation Penalties on Drugmakers in 2025
The US government will begin imposing penalties in 2025 on drug companies that charge its Medicare program prices that rise faster than inflation, the Centers for Medicare & Medicaid Services said on Thursday.
Reuters Health Information
source https://www.medscape.com/viewarticle/988114?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/988114?src=rss
Comments
Post a Comment